ABPI slams new plans for drug appraisals
The Association of the British Pharmaceutical Industry has described new proposals for evaluating medicines for NHS use as “heavy handed” and “unrealistic”.
Read More
Tag: appraisals
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
